Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases

23:46
 
Share
 

Manage episode 304643722 series 108995
By BMJ Group. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Guarav Gulsin from the University of British Columbia. They cover everything you need to know about this class of drugs for use in heart disease and beyond following the publication of a comprehensive review paper in Heart. If you enjoy the show, please subscribe to the podcast to get episodes automatically downloaded to your phone and computer. Also, please consider leaving us a review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2 Link to published paper:

https://heart.bmj.com/content/early/2021/05/09/heartjnl-2021-319185

353 episodes